Wird geladen...
BET inhibition as a new strategy for the treatment of gastric cancer
Gastric cancer is one of the most common malignancies and a leading cause of cancer death worldwide. The prognosis of stomach cancer is generally poor as this cancer is not very sensitive to commonly used chemotherapies. Epigenetic modifications play a key role in gastric cancer and contribute to th...
Gespeichert in:
Veröffentlicht in: | Oncotarget |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
Impact Journals LLC
2016
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5190074/ https://ncbi.nlm.nih.gov/pubmed/27259267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9766 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|